Literature DB >> 9788710

Recombinant allergens: the future of the diagnosis and treatment of atopic allergy.

D Kraft1, F Ferreira, C Ebner, R Valenta, H Breiteneder, M Susani, M Breitenbach, O Scheiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9788710     DOI： 10.1111/j.1398-9995.1998.tb04942.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  4 in total

1.  Clinical and immunological differences between asymptomatic HDM-sensitized and HDM-allergic rhinitis patients.

Authors:  Mihaela Zidarn; Maša Robič; Anja Krivec; Mira Šilar; Yvonne Resch-Marat; Susanne Vrtala; Peter Kopač; Nissera Bajrović; Rudolf Valenta; Peter Korošec
Journal:  Clin Exp Allergy       Date:  2019-02-27       Impact factor: 5.018

2.  [Recombinant allergens. For routine use or still only science?].

Authors:  P Schmid-Grendelmeier
Journal:  Hautarzt       Date:  2010-11       Impact factor: 0.751

3.  In planta expression of a mature Der p 1 allergen isolated from an Italian strain of Dermatophagoides pteronyssinus.

Authors:  Gianpiero Marconi; Emidio Albertini; Adriano Mari; Paola Palazzo; Andrea Porceddu; Lorenzo Raggi; Luigi Bolis; Hovirag Lancioni; Antonella Palomba; Livia Lucentini; Luisa Lanfaloni; Francesco Marcucci; Mario Falcinelli; Fausto Panara
Journal:  Transgenic Res       Date:  2011-09-09       Impact factor: 2.788

4.  Allergen-specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy.

Authors:  Birgit Winkler; Caroline Bolwig; Ulla Seppälä; Michael D Spangfort; Christof Ebner; Ursula Wiedermann
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.